Cormorant Asset Management, LP

Insider Reports History

Location
Boston, MA
Signature
CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, Its General Partner By: /s/ Bihua Chen, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cormorant Asset Management, LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. 10%+ Owner Ordinary Shares 69,465,823 $642,190,694 $9.24 18 Sep 2023 Indirect
EyePoint Pharmaceuticals, Inc. Former 10% Owner Common Stock 8,265,000 $129,793,560 $15.70 04 Dec 2025 Indirect
Ambrx Biopharma, Inc. 10%+ Owner Common Stock 11,231,000 $110,288,420 $9.82 23 Oct 2023 Indirect
Monte Rosa Therapeutics, Inc. Former 10% Owner Common Stock 3,202,200 $60,841,800 $19.00 28 Jun 2021 Indirect
Aerovate Therapeutics, Inc. Former 10% Owner Common Stock 2,030,691 $39,598,475 $19.50 02 Jul 2021 Indirect
BioAge Labs, Inc. Former 10% Owner Common Stock 1,629,529 $29,331,522 $18.00 27 Sep 2024 Indirect
Corbus Pharmaceuticals Holdings, Inc. 10%+ Owner Common Stock 2,344,971 $26,863,987 $11.46 11 Dec 2025 Indirect
Verve Therapeutics, Inc. Former 10% Owner Common Stock 984,224 $9,842,240 $10.00 21 Jun 2021 Indirect
Immuneering Corp 10%+ Owner Class A Common Stock 2,895,273 $8,598,961 $2.97 01 Apr 2024 Indirect
Tyra Biosciences, Inc. Former 10% Owner Common Stock 1,069,932 $7,039,083 $6.58 17 Sep 2021 Indirect
Icosavax, Inc. Former 10% Owner Common Stock 426,393 $6,682,644 $15.67 02 Aug 2021 Indirect
Ventyx Biosciences, Inc. Former 10% Owner Common Stock 1,410,303 $2,986,881 $2.12 25 Oct 2021 Indirect
Vigil Neuroscience, Inc. Former 10% Owner Common Stock 616,786 $2,312,948 $3.75 11 Jan 2022 Indirect
Pyxis Oncology, Inc. Former 10% Owner Common Stock 1,118,854 $1,566,396 $1.40 13 Oct 2021 Indirect
Elevation Oncology, Inc. Former 10% Owner Common Stock 2,233,168 $1,138,916 $0.5100 29 Jun 2021 Indirect
OnKure Therapeutics, Inc. Former 10% Owner Class A Common Stock 0 $0 $1.85 15 May 2025 Indirect
BRIGHT MINDS BIOSCIENCES INC. 10%+ Owner Common Shares 1,059,331 04 Nov 2024 Indirect
Aardvark Therapeutics, Inc. Former 10% Owner Common Stock 987,689 14 Feb 2025 Indirect
Aardvark Therapeutics, Inc. Former 10% Owner Series C Convertible Preferred Stock 0 14 Feb 2025 Indirect
Aerovate Therapeutics, Inc. Former 10% Owner Series A Convertible Preferred Stock 0 02 Jul 2021 Indirect
BioAge Labs, Inc. Former 10% Owner Series D Redeemable Convertible Preferred Stock 0 27 Sep 2024 Indirect
Elevation Oncology, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 29 Jun 2021 Indirect
GreenLight Biosciences Holdings, PBC Other* Common Stock 0 $0.3000 20 Jul 2023 Indirect
Icosavax, Inc. Former 10% Owner Series B-1 Convertible Preferred Stock 0 02 Aug 2021 Indirect
Monte Rosa Therapeutics, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 $2.00 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. Former 10% Owner Series C Convertible Preferred Stock 0 28 Jun 2021 Indirect
Pyxis Oncology, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 13 Oct 2021 Indirect
Tyra Biosciences, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 17 Sep 2021 Indirect
Ventyx Biosciences, Inc. Former 10% Owner Series A Convertible Preferred Stock 0 25 Oct 2021 Indirect
Ventyx Biosciences, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 25 Oct 2021 Indirect
Verve Therapeutics, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 21 Jun 2021 Indirect
Vigil Neuroscience, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 11 Jan 2022 Indirect

Insider Reports Filed by Cormorant Asset Management, LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRBP Corbus Pharmaceuticals Holdings, Inc. 11 Dec 2025 1 -$344,012 4 10%+ Owner 15 Dec 2025, 16:18
EYPT EyePoint, Inc. 04 Dec 2025 1 -$942,240 4 Former 10% Owner 08 Dec 2025, 16:03
OKUR OnKure Therapeutics, Inc. 15 May 2025 1 -$3,363,023 4 Former 10% Owner 19 May 2025, 17:33
OKUR OnKure Therapeutics, Inc. 12 May 2025 1 -$48,236 4 10%+ Owner 14 May 2025, 16:36
AARD Aardvark Therapeutics, Inc. 14 Feb 2025 3 +$3,000,000 4 Former 10% Owner 19 Feb 2025, 16:02
AARD Aardvark Therapeutics, Inc. 12 Feb 2025 0 $0 3 10%+ Owner 12 Feb 2025, 17:18
DRUG BRIGHT MINDS BIOSCIENCES INC. 04 Nov 2024 1 +$3,999,983 4 10%+ Owner 06 Nov 2024, 16:20
DRUG BRIGHT MINDS BIOSCIENCES INC. 15 Oct 2024 11 +$3,234,387 4 10%+ Owner 17 Oct 2024, 17:11
DRUG BRIGHT MINDS BIOSCIENCES INC. 15 Oct 2024 0 $0 3 10%+ Owner 17 Oct 2024, 17:07
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 10%+ Owner 15 Oct 2024, 16:08
BIOA BioAge Labs, Inc. 27 Sep 2024 3 +$8,100,000 4 Former 10% Owner 01 Oct 2024, 16:01
BIOA BioAge Labs, Inc. 25 Sep 2024 0 $0 3 10%+ Owner 25 Sep 2024, 18:43
CRBP Corbus Pharmaceuticals Holdings, Inc. 20 Sep 2024 6 +$7,003,761 4 10%+ Owner 24 Sep 2024, 16:04
EYPT EyePoint Pharmaceuticals, Inc. 06 May 2024 2 +$10,081,721 4 10%+ Owner 08 May 2024, 16:23
EYPT EyePoint Pharmaceuticals, Inc. 18 Apr 2024 2 +$10,489,446 4 10%+ Owner 22 Apr 2024, 16:00
IMRX Immuneering Corp 01 Apr 2024 8 -$1,160,181 4 10%+ Owner 03 Apr 2024, 17:37
IMRX Immuneering Corp 14 Mar 2024 5 -$2,749,003 4 10%+ Owner 18 Mar 2024, 17:59
CRBP Corbus Pharmaceuticals Holdings, Inc. 07 Mar 2024 10 +$23,327,560 4 10%+ Owner 11 Mar 2024, 17:34
CRBP Corbus Pharmaceuticals Holdings, Inc. 02 Feb 2024 1 +$14,250,000 4 10%+ Owner 06 Feb 2024, 16:00
CRBP Corbus Pharmaceuticals Holdings, Inc. 26 Jan 2024 14 +$9,111,941 4 10%+ Owner 30 Jan 2024, 16:23
CRBP Corbus Pharmaceuticals Holdings, Inc. 26 Jan 2024 0 $0 3 10%+ Owner 30 Jan 2024, 16:18
EYPT EyePoint Pharmaceuticals, Inc. 09 Jan 2024 2 +$17,051,100 4 10%+ Owner 11 Jan 2024, 16:00
EYPT EyePoint Pharmaceuticals, Inc. 08 Dec 2023 1 +$9,999,995 4 10%+ Owner 12 Dec 2023, 16:52
EYPT EyePoint Pharmaceuticals, Inc. 04 Dec 2023 17 +$41,874,151 4 10%+ Owner 06 Dec 2023, 16:39
EYPT EyePoint Pharmaceuticals, Inc. 04 Dec 2023 0 $0 3 10%+ Owner 06 Dec 2023, 16:38
AMAM Ambrx Biopharma, Inc. 23 Oct 2023 1 +$9,139,542 4 10%+ Owner 25 Oct 2023, 16:15
/report/000092963823002564-cormorant-asset-management-lp-2023-09-15 Ambrx Biopharma Inc. 15 Sep 2023 2 +$19,625,601 4 10%+ Owner 19 Sep 2023, 16:49
/report/000092963823002058-cormorant-asset-management-lp-2023-07-20 GreenLight Biosciences Holdings, PBC 20 Jul 2023 1 $0 4 Other* 24 Jul 2023, 16:01
/report/000092963823001698-cormorant-asset-management-lp-2023-05-29 GreenLight Biosciences Holdings, PBC 29 May 2023 0 $0 3 Other* 08 Jun 2023, 17:12
IMRX Immuneering Corp 20 Apr 2023 0 $0 3 10%+ Owner 24 Apr 2023, 17:21
/report/000092963823001211-cormorant-asset-management-lp-2023-04-18 Ambrx Biopharma Inc. 18 Apr 2023 3 +$58,950,690 4 10%+ Owner 20 Apr 2023, 18:04
/report/000092963823001185-cormorant-asset-management-lp-2023-04-13 Ambrx Biopharma Inc. 13 Apr 2023 3 +$25,319,289 4 10%+ Owner 17 Apr 2023, 17:46
/report/000092963823000867-cormorant-asset-management-lp-2023-03-14 Ambrx Biopharma Inc. 14 Mar 2023 3 +$10,211,400 4 10%+ Owner 16 Mar 2023, 18:04
/report/000092963823000831-cormorant-asset-management-lp-2023-03-03 Ambrx Biopharma Inc. 03 Mar 2023 0 $0 3 10%+ Owner 13 Mar 2023, 16:01
VIGL Vigil Neuroscience, Inc. 11 Jan 2022 2 $0 4 Former 10% Owner 13 Jan 2022, 15:06
VIGL Vigil Neuroscience, Inc. 06 Jan 2022 0 $0 3 10%+ Owner 06 Jan 2022, 15:28
VTYX Ventyx Biosciences, Inc. 25 Oct 2021 4 +$10,000,000 4 Former 10% Owner 27 Oct 2021, 16:04
VTYX Ventyx Biosciences, Inc. 20 Oct 2021 0 $0 3 10%+ Owner 20 Oct 2021, 17:19
PYXS Pyxis Oncology, Inc. 13 Oct 2021 3 +$7,200,000 4 Former 10% Owner 15 Oct 2021, 16:12
PYXS Pyxis Oncology, Inc. 07 Oct 2021 0 $0 3 10%+ Owner 07 Oct 2021, 17:05
TYRA Tyra Biosciences, Inc. 17 Sep 2021 3 +$5,000,000 4 Former 10% Owner 21 Sep 2021, 16:03
TYRA Tyra Biosciences, Inc. 14 Sep 2021 0 $0 3 10%+ Owner 14 Sep 2021, 16:35
IMRX Immuneering Corp 03 Aug 2021 3 +$8,250,000 4 Former 10% Owner 05 Aug 2021, 16:01
/report/000156761921014403-cormorant-asset-management-lp-2021-08-02 Icosavax, Inc. 02 Aug 2021 2 $0 4 Former 10% Owner 04 Aug 2021, 16:02
IMRX Immuneering Corp 29 Jul 2021 0 $0 3 10%+ Owner 29 Jul 2021, 16:54
/report/000156761921014100-cormorant-asset-management-lp-2021-07-28 Icosavax, Inc. 28 Jul 2021 0 $0 3 10%+ Owner 28 Jul 2021, 16:24
JBIO Aerovate Therapeutics, Inc. 02 Jul 2021 3 +$7,000,000 4 Former 10% Owner 07 Jul 2021, 16:45
ELEV Elevation Oncology, Inc. 29 Jun 2021 3 +$4,000,000 4 Former 10% Owner 01 Jul 2021, 16:24
JBIO Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 10%+ Owner 29 Jun 2021, 17:09
GLUE Monte Rosa Therapeutics, Inc. 28 Jun 2021 4 +$11,400,000 4 Former 10% Owner 30 Jun 2021, 16:08
ELEV Elevation Oncology, Inc. 24 Jun 2021 0 $0 3 10%+ Owner 24 Jun 2021, 17:14
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 10%+ Owner 23 Jun 2021, 18:09
VERV Verve Therapeutics, Inc. 21 Jun 2021 3 +$5,225,000 4 Former 10% Owner 23 Jun 2021, 16:02
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 16:55